Literature DB >> 2493414

Relationship between oxygen transport and oxygen uptake in patients with cirrhosis: effects of vasoactive drugs.

R Moreau1, S S Lee, A Hadengue, Y Ozier, C Sicot, D Lebrec.   

Abstract

To elucidate the relationship between oxygen transport and uptake in cirrhosis, we studied the effects of three vasoactive drugs that change O2 transport. Systemic hemodynamics, blood gases and lactate concentration were measured in patients with alcoholic cirrhosis before and after intravenous dobutamine, propranolol and nitroglycerin. Nine patients received successively dobutamine and then propranolol. Ten patients received nitroglycerin. Three other patients without cirrhosis (controls) received dobutamine. In patients with cirrhosis, dobutamine infusion was accompanied by a significant increase in cardiac output (+21%), systemic O2 transport (+21%) and O2 uptake (+12%), whereas O2 extraction ratio and arterial lactate concentration did not change significantly. Propranolol administration was followed by a significant decrease in cardiac output (-24%) and systemic O2 transport (-25%) and a significant increase in O2 extraction ratio (+19%), whereas O2 uptake and arterial lactate concentration did not change. Nitroglycerin infusion was accompanied by a significant decrease in cardiac output (-21%), systemic O2 transport (-26%) and O2 uptake (-10%), whereas O2 extraction ratio (+18%) and arterial lactate concentration (+31%) significantly increased. In control patients, dobutamine infusion was accompanied by an increase in cardiac output and in systemic O2 transport and by a decrease in O2 extraction ratio, whereas O2 uptake was not modified. These results suggest that O2 uptake may be abnormally dependent on O2 transport in patients with cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493414     DOI: 10.1002/hep.1840090314

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Chronic splanchnic hemodynamic effects of low-dose transdermal nitroglycerin versus low-dose transdermal nitroglycerin plus spironolactone in patients with cirrhosis.

Authors:  S Sugano; T Suzuki; M Nishio; H Makino; T Okajima
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

2.  Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted?

Authors:  H R Doyle; I R Marino; N Jabbour; G Zetti; J McMichael; S Mitchell; J Fung; T E Starzl
Journal:  Transplantation       Date:  1994-04-15       Impact factor: 4.939

Review 3.  Cardiac abnormalities in liver cirrhosis.

Authors:  S S Lee
Journal:  West J Med       Date:  1989-11

4.  Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective beta-blocker.

Authors:  F Vachiery; R Moreau; A Gadano; S Yang; P Sogni; A Hadengue; S Cailmail; T Soupison; D Lebrec
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

5.  Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort.

Authors:  Lukasz A Myc; Jonathan G Stine; Rinita Chakrapani; Alexandra Kadl; Curtis K Argo
Journal:  World J Hepatol       Date:  2017-01-18

6.  Is NMDA-Receptor-Mediated Oxidative Stress in Mitochondria of Peripheral Tissues the Essential Factor in the Pathogenesis of Hepatic Encephalopathy?

Authors:  Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
Journal:  J Clin Med       Date:  2022-02-04       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.